We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH Meeting FDASIA Goals, Confirms Compliance Re-Org
WASHINGTON, D.C. — CDRH currently is returning about 60 percent of newly filed 510(k)s to medtech sponsors, the majority for lack of shelf life and biocompatibility information, according to center Director Jeffrey Shuren.